NNNN

Dopo l'orario di chiusura: 6.75 -0.010 -0.15%

Anbio Biotechnology (NNNN)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Anbio Biotechnology Stock (NNNN) Company Profile

Anbio Biotechnology

Healthcare (1189)

Prossima data di guadagno

Ultimi documenti SEC

NNNN's Discussions on Twitter

Confronta NNNN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NNNN Anbio Biotechnology	6.76	337.96M	0	0	0	0.00
ISRG Intuitive Surgical Inc	566.98	205.74B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	228.45	65.11B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	94.14	46.26B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	233.10	34.51B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	91.65	18.19B	3.90B	392.30M	288.10M	1.95

Anbio Biotechnology Borsa (NNNN) Ultime notizie

Anbio Biotechnology Azioni (NNNN) Dati Finanziari

Non sono disponibili dati finanziari per Anbio Biotechnology (NNNN). Controlla altri titoli per ulteriori informazioni.

Anbio Biotechnology (NNNN)

Anbio Biotechnology Stock (NNNN) Company Profile

Confronta NNNN con altri titoli

Anbio Biotechnology Borsa (NNNN) Ultime notizie

Kestra Medical ups IPO target to $150M - BioWorld Online

Unlocking Anbio's IPO: A Pivotal Shift in Global Diagnostics! - Mi Valle

U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings - Seeking Alpha

IPO NewsUS IPO Weekly Recap: IPO calendar slows down with small listings - Renaissance Capital

Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps - Yahoo Finance

Anbio Biotechnology prices $8M IPO at $5 per share - MSN

Anbio Biotechnology’s IPO opens up 5% - Investing.com

Anbio Biotechnology’s IPO Set to Revolutionize Global Diagnostics - Mi Valle

NNNNAnbio Biotechnology Latest Stock News & Market Updates - StockTitan

Anbio Biotechnology to Showcase Cutting-Edge Diagnostic Solutions at 2025 Medlab Middle East - PR Newswire

Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency - PR Newswire

Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch - Seeking Alpha

Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024 - PR Newswire

Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions - PR Newswire

Anbio advances POC testing with new FIA analyzer - SelectScience

Anbio Biotechnology to Showcase ABO & Rhd Blood Grouping Kit at Medlab Middle East 2024 - PR Newswire

Anbio Biotechnology to Present at Medlab Middle East on February 5th, 2024. - PR Newswire

Anbio Biotechnology made a successful first presence at AACC Middle East 2023 - BioSpace

Handheld Analyzer Uses LAMP Diagnostic Technique for Rapid, Point-of-Care Testing - HospiMedica

Anbio Biotechnology Highlights the Future of Diagnostic Solutions at AACC 2023 - PR Newswire

Anbio launches fluorescent immunoassay analyzer for rapid, point-of-care testing - BioWorld Online

Introducing the Anbio LAMP Solution: A Small, Yet Powerful Handheld Analyzer for Rapid, Point-of-Care Testing - PR Newswire

Anbio introduces fluorescent Immunoassay solution for patient care - Medical Device Network

Introducing the Anbio AF-100S: A Small, Yet Powerful Handheld Analyzer for Rapid, Point-of-Care Testing - PR Newswire

Introducing the Anbio ADL i1910: An Elegant CLIA Analyzer for Comprehensive Clinical Testing - PR Newswire

Anbio Biotechnology to Participate in the 2023 AACC Meeting - PR Newswire

AnHeart Therapeutics Raises $61 Million in Oversubscribed Series B Financing to Advance Precision Oncology Pipeline - Business Wire

Anbio Biotechnology Azioni (NNNN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a NNNN